Back
Hansa Biopharma AB 10K Form
Sell
29
HNSBF
Hansa Biopharma AB
Last Price:
$2.91
Seasonality Move:
-3.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HNSBF News And Ratings
See the #1 stock for the next 7 days that we like better than HNSBF
HNSBF Financial Statistics
Sales & Book Value
| Annual Sales: | $16.2M |
|---|---|
| Cash Flow: | $-9.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.70 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.87460 |
|---|---|
| Net Income (TTM): | $-63.2M |
| Gross Margin: | $7.3M |
| Return on Equity: | 0% |
| Return on Assets: | -78.59% |
Hansa Biopharma AB Earnings Forecast
Key Hansa Biopharma AB Financial Ratios
-
The Gross Profit Margin over the past 18 years for HNSBF is 45.34%.
-
The Selling, General & Administrative Expenses for HNSBF have been equal to 200.96% of Gross Profit Margin.
-
The Research & Development expenses have been 210.47% of Revenue.
-
The Net Earning history of HNSBF is -471.20% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 4 years.
Hansa Biopharma AB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | HNSBF |
| Website: | hansabiopharma.com |
Debt
| Debt-to-Equity Ratio: | -1.65 |
|---|---|
| Current Ratio: | 1.11 |
| Quick Ratio: | 1 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HNSBF Technical Analysis vs Fundamental Analysis
Sell
29
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy or a Sell?
-
Hansa Biopharma AB stock is rated a SellThe current Hansa Biopharma AB [HNSBF] share price is $2.91. The Score for HNSBF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.